Acceleration of Advanced CN Antidote Agents for Mass Exposure Treatments: DMTS
Abstract
The overall goal of this 2 year project was to utilize novel, real-time noninvasive in vivo optical spectroscopic detection methods to investigate potential breakthrough CN poisoning treatment agents, including DMTS alone or with sulfanegen and/or cobinamide, which will be useful for intramuscular (IM) delivery in mass casualty cyanide poisoning settings.
Document Details
- Document Type
- Technical Report
- Publication Date
- Dec 01, 2014
- Accession Number
- ADA613637
Entities
People
- Matthew Brenner
Organizations
- Beckman Laser Institute